Pages that link to "Q73341072"
Jump to navigation
Jump to search
The following pages link to Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease (Q73341072):
Displaying 50 items.
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Q22299313) (← links)
- The history of COPD (Q22305861) (← links)
- Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes (Q22306079) (← links)
- Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis (Q24197853) (← links)
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease (Q24197989) (← links)
- Inhaled corticosteroids for stable chronic obstructive pulmonary disease (Q24202092) (← links)
- Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease (Q24234164) (← links)
- Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children (Q24235303) (← links)
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma (Q24235964) (← links)
- Inhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease (Q24236037) (← links)
- Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children (Q24240464) (← links)
- Inhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary disease (Q24243419) (← links)
- Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease (Q24243564) (← links)
- Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma (Q24245383) (← links)
- Inhaled corticosteroids for stable chronic obstructive pulmonary disease (Q24245481) (← links)
- Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma (Q24245643) (← links)
- Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults (Q24245719) (← links)
- Oral corticosteroids for stable chronic obstructive pulmonary disease (Q24246556) (← links)
- Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease (Q24246591) (← links)
- Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis (Q24797765) (← links)
- Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic? (Q26777927) (← links)
- Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma (Q26780553) (← links)
- Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities (Q26795662) (← links)
- Positioning new pharmacotherapies for COPD (Q26798659) (← links)
- A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease (Q26801661) (← links)
- Lung cancer chemoprevention: current status and future prospects (Q26995495) (← links)
- Lung function decline in COPD (Q27024993) (← links)
- Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal (Q28074169) (← links)
- Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease (Q28389152) (← links)
- Epidemiology and management of common pulmonary diseases in older persons (Q28397465) (← links)
- Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease (Q28761895) (← links)
- Asthma-COPD Overlap Syndrome: What We Know and What We Don't (Q30238799) (← links)
- COPD exacerbations. 4: Prevention (Q30480789) (← links)
- Effectiveness of inhaled corticosteroids in chronic obstructive lung disease: systematic review (Q30832660) (← links)
- Bronchodilators in COPD: latest recommendations, recent data and perspectives (Q30913428) (← links)
- The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings (Q33532293) (← links)
- Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update (Q33591899) (← links)
- Categorizing asthma severity: an overview of national guidelines (Q33723527) (← links)
- Recent advances: Respiratory medicine. (Q33808282) (← links)
- Influencing the decline of lung function in COPD: use of pharmacotherapy (Q33966001) (← links)
- The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD. (Q33966009) (← links)
- Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis (Q33995219) (← links)
- Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective (Q34065276) (← links)
- An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease (Q34065958) (← links)
- Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results (Q34074832) (← links)
- Respiratory medicine. (Q34247647) (← links)
- Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease (Q34289898) (← links)
- Nebulized corticosteroids in the management of acute exacerbation of COPD (Q34332863) (← links)
- Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors (Q34355113) (← links)
- Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease? (Q34385357) (← links)